Data / Form D filings / GenoPalate, Inc.
GenoPalate, Inc.: Form D filings
GenoPalate, Inc., a biotechnology company in Milwaukee, WI, filed 8 Form D notices with the SEC between 2018 and 2026. The latest, on March 4, 2026, reports $250,000 sold of a $3 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 10437 W INNOVATION DR STE 465, Milwaukee, WI, 53226
- Phone
- (414) 801-6686
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1736000
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Mar 4, 2026 | New notice | $3,000,000 | $250,000 | $2,750,000 | 1 | Feb 9, 2026 | sec.gov |
| Dec 10, 2024 | New notice | $10,000,000 | $3,000,000 | $7,000,000 | 4 | Oct 3, 2024 | sec.gov |
| Oct 21, 2022 | New notice | $11,086,498 | $6,047,456 | $5,039,042 | 6 | Oct 7, 2022 | sec.gov |
| Dec 29, 2020 | New notice | $3,999,955 | $3,999,955 | 9 | Dec 15, 2020 | sec.gov | |
| Dec 16, 2019 | New notice | $3,000,000 | $1,000,000 | $2,000,000 | 1 | Dec 2, 2019 | sec.gov |
| Dec 3, 2018 | New notice | $1,514,104 | $709,095 | $805,009 | 8 | Nov 19, 2018 | sec.gov |
| May 3, 2018 | Amendment | $357,065 | $357,065 | 6 | Mar 19, 2018 | sec.gov | |
| Mar 30, 2018 | New notice | $307,066 | $307,066 | 6 | Mar 19, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Joseph M. Smith | Director | |
| Harald Steltzer | Director | |
| John T. Byrnes | Director | |
| Asif Naseem | Executive Officer, Director | |
| Yi Zhang | Director | |
| Michael McNally | Executive Officer |
Every Form D from the week of Mar 2, 2026 · All recent filings in Wisconsin · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what GenoPalate, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.